References

  1. Ihara, M., Yamamoto, Y., Hattori, Y., Liu, W., Kobayashi, H., Ishiyama, H., Yoshimoto, T., Miyawaki, S., Clausen, T., Bang, O. Y., Steinberg, G. K., Tournier-Lasserve, E., & Koizumi, A. (2022). Moyamoya disease: diagnosis and interventions. The Lancet Neurology, 21(8), 747–758. https://doi.org/10.1016/s1474-4422(22)00165-x
  2. Benkhaira, N., Kerouaz, N., & Kitouni, Y. (2022). Syndrome de Moya-Moya chez une adulte révélé par une thrombose veineuse cérébrale : à propos d’un cas. La Revue De Médecine Interne, 43, A219–A220. https://doi.org/10.1016/j.revmed.2022.03.168
  3. Wang, X., Zou, Z., Bao, X., Wang, Q., Ren, B., Yu, D., Zhang, Q., Liu, J., Hao, F., Gao, G., Guo, Q., Fu, H., Li, J., Wang, M., Liu, S., & Duan, L. (2024). Clinical and genetic factors associated with contralateral progression in unilateral moyamoya disease: Longitudinal and Cross-Sectional Study. Heliyon, e26108. https://doi.org/10.1016/j.heliyon.2024.e26108
  4. Li, J., Wang, X., Wang, Q., Bao, X., Guo, Q., Kong, Z., Gao, G., Wang, M., Liu, S., Fu, H., Zhang, Q., & Duan, L. (2023). Long-term outcomes after conservative and EDAS treatment for 111 elderly patients with moyamoya disease: longitudinal and cross-sectional study. Journal of Neurosurgery, 140(3), 800–808. https://doi.org/10.3171/2023.7.jns231060
  5. Pashkov, A., Filimonova, E., Martirosyan, A., Ovsyannikov, K., Gunenko, G., Moysak, G., & Rzaev, J. (2023). Profile of speech and cognitive impairments in a patient with moyamoya disease: a longitudinal case study. medRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2023.08.29.23294546
  6. Araki, Y., Takagi, Y., Ueda, K., Ubukata, S., Ishida, J., Funaki, T., Kikuchi, T., Takahashi, J. C., Murai, T., & Miyamoto, S. (2014). Cognitive Function of Patients with Adult Moyamoya Disease. Journal of Stroke and Cerebrovascular Diseases, 23(7), 1789–1794. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.04.032
  7. Nielsen, T. H., Abhinav, K., Sussman, E. S., Han, S. S., Weng, Y., Bell-Stephens, T., Cnrn, N., Heit, J. J., & Steinberg, G. K. (2020). Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy. Journal of Neurosurgery, 134(5), 1578–1589. https://doi.org/10.3171/2020.3.jns192847
  8. Kim, E., Lee, H., Chung, J., Ji, S., Jang, Y., Lee, J., Kim, J., & Kim, H. (2020). Flow-Mediated Dilatation of the Brachial Artery for Assessing Endothelial Dysfunction in Children with Moyamoya Disease.Pediatric Neurosurgery , 55 (3), 149–154. https://doi.org/10.1159/000509406
  9. Toh, K. Z., Koh, M. Y., Loh, E. D., Sia, C., Chong, Y., Yeo, L. L., Sharma, V. K., Lim, M. J., & Tan, B. Y. (2023). Prevalence and Associations of Cognitive Impairment in Adult Patients with Moyamoya Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer S Disease, 97(2), 541–552. https://doi.org/10.3233/jad-230979
  10. Sperber, C., & Karnath, H. (2015). Topography of acute stroke in a sample of 439 right brain damaged patients. NeuroImage Clinical , 10 , 124–128. https://doi.org/10.1016/j.nicl.2015.11.012
  11. Memetoglu, O. G., Taraktas, A., Badur, N. B., & Ozkan, F. U. (2014). Impact of stroke etiology on clinical symptoms and functional status.Northern Clinics of Istanbul , 1 (2). https://doi.org/10.14744/nci.2014.40327
  12. Ahtam, B., Solti, M., Doo, J. M., Feldman, H. A., Vyas, R., Zhang, F., O’Donnell, L. J., Rathi, Y., Smith, E. R., Orbach, D., See, A. P., Grant, P. E., & Lehman, L. L. (2023). Diffusion-Weighted Magnetic Resonance Imaging Demonstrates White Matter Alterations in Watershed Regions in Children With Moyamoya Without Stroke or Silent Infarct.Pediatric Neurology , 143 , 89–94. https://doi.org/10.1016/j.pediatrneurol.2023.03.005
  13. Liu, Z., He, S., Xu, Z., Duan, R., Yuan, L., Xiao, C., Yi, Z., & Wang, R. (2020). Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease.BMC Neurology , 20 (1). https://doi.org/10.1186/s12883-020-01876-0
  14. Yamada, Y., Matsui, K., Takeuchi, I., & Fujimaki, T. (2015). Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study. Biomedical Reports , 3 (3), 413–419. https://doi.org/10.3892/br.2015.440
  15. Sun, W., Ruan, Z., Dai, X., Li, S., Li, S., Zhang, J., Chen, J., Zhang, H., & Xu, H. (2018). Quantifying Hemodynamic Changes in Moyamoya Disease Based on Two-Dimensional Cine Phase-Contrast Magnetic Resonance Imaging and Computational Fluid Dynamics. World Neurosurgery , 120 , e1301–e1309. https://doi.org/10.1016/j.wneu.2018.09.057
  16. Su, H., & Yu, J. (2024). Effect of moyamoya disease on the basilar artery and adjacent arteries on CTA. eNeurologicalSci , 100501. https://doi.org/10.1016/j.ensci.2024.100501
  17. Yamamoto, S., Funaki, T., Fujimura, M., Takahashi, J. C., Uchino, H., Houkin, K., Tominaga, T., Miyamoto, S., & Kuroda, S. (2019). Development of Hemorrhage-prone Anastomoses in Asymptomatic Moyamoya Disease—A Comparative Study with Japan Adult Moyamoya Trial.Journal of Stroke and Cerebrovascular Diseases , 28 (11), 104328. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104328
  18. Jang, D., Lee, K., Rha, H. K., Huh, P., Yang, J., Park, I. S., Ahn, J., Sung, J. H., & Han, Y. (2016). Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. Journal of Neurosurgery , 127 (3), 492–502. https://doi.org/10.3171/2016.8.jns152875
  19. Yamamoto, Y., Nagakane, Y., Makino, M., Ohara, T., Koizumi, T., Makita, N., & Akiguchi, I. (2014). Aggressive Antiplatelet Treatment for Acute Branch Atheromatous Disease Type Infarcts: A 12-year Prospective Study. International Journal of Stroke ,9 (3), E8. https://doi.org/10.1111/ijs.12200